These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36276871)

  • 21. The Mechanism of Traditional Chinese Medicine Based on Semi-Targeted Metabolomics to Improve IVF Outcomes in Senile Patients.
    Ma YJ; Yuan LH; Xiao JM; Jiang HY; Sa YH; Sun HQ; Song JY; Sun ZG
    Evid Based Complement Alternat Med; 2021; 2021():6696305. PubMed ID: 34804183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GnRH Agonist and hCG (Dual Trigger) Versus hCG Trigger for Final Oocyte Maturation in Expected Normal Responders With a High Immature Oocyte Rate: Study Protocol for a Randomized, Superiority, Parallel Group, Controlled Trial.
    Yan MH; Cao JX; Hou JW; Jiang WJ; Wang DD; Sun ZG; Song JY
    Front Endocrinol (Lausanne); 2022; 13():831859. PubMed ID: 35418945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of electroacupuncture on oocyte quality and pregnancy for patients with PCOS undergoing in vitro fertilization and embryo transfervitro fertilization and embryo transfer].
    Cui W; Li J; Sun W; Wen J
    Zhongguo Zhen Jiu; 2011 Aug; 31(8):687-91. PubMed ID: 21894688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significance of pro-angiogenic estrogen metabolites in normal follicular development and follicular growth arrest in polycystic ovary syndrome.
    Henríquez S; Kohen P; Xu X; Villarroel C; Muñoz A; Godoy A; Strauss JF; Devoto L
    Hum Reprod; 2020 Jul; 35(7):1655-1665. PubMed ID: 32558920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Analysis of the clinical outcomes of IVF-ET treatment in infertile patients with polycystic ovary syndrome or polycystic ovaries].
    Wang QL; Song J; Chen SL; Luo C; Chen X; Li M; Ni YP
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 May; 29(5):962-5. PubMed ID: 19460721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic alterations associated with polycystic ovary syndrome: A UPLC Q-Exactive based metabolomic study.
    Chen X; Lu T; Wang X; Sun X; Zhang J; Zhou K; Ji X; Sun R; Wang X; Chen M; Ling X
    Clin Chim Acta; 2020 Mar; 502():280-286. PubMed ID: 31758934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer.
    Doldi N; Persico P; Di Sebastiano F; Marsiglio E; Ferrari A
    Gynecol Endocrinol; 2006 May; 22(5):235-8. PubMed ID: 16785142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of sex hormone-binding globulin polymorphisms on the outcome of in vitro fertilization-embryo transfer for polycystic ovary syndrome patients: A case-control study.
    Liu Y; Zhao XX; Hu XJ; Yang F; Lin P; Cui SC; Zhao W; Cao XY; Wang YS
    J Cell Biochem; 2019 Mar; 120(3):4675-4686. PubMed ID: 30520140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ovarian response to controlled ovarian stimulation in women with different polycystic ovary syndrome phenotypes.
    Cela V; Obino MER; Alberga Y; Pinelli S; Sergiampietri C; Casarosa E; Simi G; Papini F; Artini PG
    Gynecol Endocrinol; 2018 Jun; 34(6):518-523. PubMed ID: 29271274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolomics analysis of follicular fluid in women with ovarian endometriosis undergoing in vitro fertilization.
    Karaer A; Tuncay G; Mumcu A; Dogan B
    Syst Biol Reprod Med; 2019 Feb; 65(1):39-47. PubMed ID: 29806498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome.
    Tso LO; Costello MF; Albuquerque LET; Andriolo RB; Macedo CR
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD006105. PubMed ID: 33347618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of potential metabolic biomarkers of polycystic ovary syndrome in follicular fluid by SWATH mass spectrometry.
    Sun Z; Chang HM; Wang A; Song J; Zhang X; Guo J; Leung PCK; Lian F
    Reprod Biol Endocrinol; 2019 Jun; 17(1):45. PubMed ID: 31186025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A simplified universal approach to COH protocol for IVF: ultrashort flare GnRH-agonist/GnRH-antagonist protocol with tailored mode and timing of final follicular maturation.
    Orvieto R
    J Ovarian Res; 2015 Nov; 8():69. PubMed ID: 26536862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular endothelial growth factor and basic fibroblast growth factor in polycystic ovary syndrome during controlled ovarian hyperstimulation.
    Artini PG; Monti M; Matteucci C; Valentino V; Cristello F; Genazzani AR
    Gynecol Endocrinol; 2006 Aug; 22(8):465-70. PubMed ID: 17012110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Substituting human chorionic gonadotropin by gonadotropin-releasing hormone agonist to trigger final follicular maturation, during controlled ovarian hyperstimulation, results in less systemic inflammation.
    Orvieto R; Zagatsky I; Yulzari-Roll V; La Marca A; Fisch B
    Gynecol Endocrinol; 2006 Aug; 22(8):437-40. PubMed ID: 17012105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.
    Toftager M; Bogstad J; Bryndorf T; Løssl K; Roskær J; Holland T; Prætorius L; Zedeler A; Nilas L; Pinborg A
    Hum Reprod; 2016 Jun; 31(6):1253-64. PubMed ID: 27060174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is early-follicular long-acting GnRH agonist protocol an alternative for patients with polycystic ovary syndrome undergoing in vitro fertilization?
    Wang D; Chu T; Yu T; Zhai J
    Reprod Biol Endocrinol; 2022 Sep; 20(1):137. PubMed ID: 36088329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Follicular fluid vascular endothelial growth factor in normal and hyperresponder females and how it is affected by the type of trigger.
    Mahmood MK; Alsultany BA; Jassim IY
    J Pak Med Assoc; 2021 Dec; 71(Suppl 9)(12):S56-S58. PubMed ID: 35130262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparative study on the outcomes of in vitro fertilization between women with polycystic ovary syndrome and those with sonographic polycystic ovary-only in GnRH antagonist cycles.
    Kim YJ; Ku SY; Jee BC; Suh CS; Kim SH; Choi YM; Kim JG; Moon SY
    Arch Gynecol Obstet; 2010 Aug; 282(2):199-205. PubMed ID: 20182736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C-reactive protein levels in patients undergoing controlled ovarian hyperstimulation for IVF cycle.
    Orvieto R; Chen R; Ashkenazi J; Ben-Haroush A; Bar J; Fisch B
    Hum Reprod; 2004 Feb; 19(2):357-9. PubMed ID: 14747180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.